Stocks and Investing Stocks and Investing
Fri, June 2, 2023
Thu, June 1, 2023

Ed Arce Reiterated (TVTX) at Strong Buy with Increased Target to $35 on, Jun 1st, 2023


Published on 2024-10-28 04:09:05 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Reiterated "Travere Therapeutics, Inc." (TVTX) at Strong Buy with Increased Target from $22 to $35 on, Jun 1st, 2023.

Ed has made no other calls on TVTX in the last 4 months.



There are 9 other peers that have a rating on TVTX. Out of the 9 peers that are also analyzing TVTX, 0 agree with Ed's Rating of Hold.



These are the ratings of the 9 analyists that currently disagree with Ed


  • Tyler Van Buren of "TD Cowen" Initiated at Buy and Held Target at $30 on, Monday, May 22nd, 2023
  • Vamil Divan of "Guggenheim" Maintained at Strong Buy with Decreased Target to $23 on, Tuesday, May 2nd, 2023
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Decreased Target to $26 on, Tuesday, May 2nd, 2023
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Decreased Target to $24 on, Tuesday, May 2nd, 2023
  • Greg Harrison of "B of A Securities" Maintained at Strong Buy with Decreased Target to $39 on, Tuesday, May 2nd, 2023
  • Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $29 on, Monday, April 17th, 2023
  • Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $42 on, Tuesday, February 28th, 2023
  • Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $31 on, Tuesday, February 21st, 2023
  • Do Kim of "Piper Sandler" Maintained at Buy with Increased Target to $46 on, Tuesday, February 21st, 2023
Contributing Sources